Lilly Eyes Top 10 Japan Ranking Built On Stream Of Launches
Executive Summary
Lilly says it remains on track to enter the pharma industry top 10 in Japan by sales by 2020, driven by planned launches of a raft of new products and despite some major recent losses of exclusivity.